PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2019 | 65 | 3 |

Tytuł artykułu

The in vitro activity of selected mouthrinses on the reference strains of Trichomonas tenax and Entamoeba gingivalis

Treść / Zawartość

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Protozoa, such as Trichomonas tenax, Entamoeba gingivalis and Leishmania braziliensis, may be present in the mouth but their role in the pathophysiology of oral diseases is not clear yet. The use of various types of mouthrinses plays an important role in maintaining proper oral hygiene and in removing some of the microbial components from the oral cavity. The purpose of this study was to investigate the effects of selected mouthrinses on the reference strains of Trichomonas tenax and Entamoeba gingivalis which can be a part of the oral cavity microbiota. Two standard strains Trichomonas tenax (ATCC 30207) and Entamoeba gingivalis (ATCC 30927) were used and metronidazole as a drug used in the treatment of infections caused by protozoa as well as fourteen agents used as mouthwashes were tested, with two pure compounds acting as mouthrinse ingredients, i.e. 20% benzocaine and 0.2% chlorhexidine, as well as 12 commercially-available formulas: Azulan, Colgate Plax Complete Care Sensitive, Corsodyl 0.2%, Curasept ADS 205, Dentosept, Dentosept A, Eludril Classic, Listerine Total Care, Octenidol, Oral-B Pro-Expert Clinic Line, Sylveco and Tinctura salviae. The protozoonicidal activity of the preparations was evaluated on the basis of the ratio of dead to living ratios after incubation in an incubator (37°C) for 1, 10 and 30 min. Protozoa were counted in the Bürker chamber in each case up to 100 cells in an optical microscope (over 400×). The criterion for the death of protozoa was the lack of movement and changes in the shape and characteristics of cell disintegration. The curves of activity were obtained after experiments conducted for 5–7 different solutions of each preparation. On the basis of the curves, the solution killing 50% of the population (CL₅₀) was calculated. All mouthrinses tested in this work in their undiluted form acted lethally on both protozoa. Benzocaine, used as a local anesthetic, has etiotropic properties which can be useful for supporting antiprotozoal treatment. Chlorhexidine confirmed its high efficiency in the eradication of potentially pathogenic protozoa. The use of mouthrinses is an important complement for other procedures intended to maintain correct oral hygiene.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

65

Numer

3

Opis fizyczny

p.257-265,fig.,ref.

Twórcy

autor
  • Chair of Biology and Medical Parasitology, Medical University of Łódź, ul.Żeligowskiego 7/9, 90-752 Łódź, Poland
  • Health Institute, The Angelus Silesius University of Applied Sciences in Wałbrzych, Poland
  • Health Institute, The Angelus Silesius University of Applied Sciences in Wałbrzych, Poland

Bibliografia

  • [1] Krishnan K., Chen T., Paster B.J. 2017. A practical guide to the oral microbiome and its relation to health and disease. Oral Diseases 23: 276-286. doi:10.1111/odi.12509
  • [2] Sender R., Fuchs S., Milo R. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biology 14: e1002533. doi:10.1371/journal.pbio.1002533
  • [3] Sultan A.S., Kong E.F., Rizk A.M., Jabra-Rizk M.A. 2018. The oral microbiome: A lesson in coexistence. PLoS Pathogens 14: e1006719. doi:10.1371/journal.ppat.1006719
  • [4] https://www.human-microbiome.org
  • [5] Ghannoum M.A., Jurevic R.J., Mukherjee P.K., Cui F., Sikaroodi M., Naqvi A., Gillevet P.M. 2010. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathogens 6: e1000713. doi:10.1371/journal.ppat.1000713
  • [6] Malinowska M., Tokarz-Deptuła B., Deptuła W. 2017. Mikrobiom człowieka. Postępy Mikrobiologii 56: 33-42 (in Polish with summary in English).
  • [7] Murray P.R., Rosenthal K.S., Pfaller M.A. 2016. Medical microbiology. Elsevier.
  • [8] Naglik J.R., Tang S.X., Moyes D.L. 2013. Oral colonization of fungi. Current Fungal Infection Reports 7: 152-159. doi:10.1007/s12281-013-0129-y
  • [9] Samaranayake L.P. 2018. Essential microbiology for dentistry. Elsevier.
  • [10] The Human Oral Microbiome. Database http://www.homd.org
  • [11]Verma D., Garg P.K., Dubey A.K. 2018. Insights into the human oral microbiome. Archives of Microbiology 200: 525-540. doi:10.1007/s00203-018-1505-3
  • [12] Lamont R.J., Hajishengallis G. 2015. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends in Molecular Medicine 21:172-183. doi:10.1016/j.molmed.2014.11.004
  • [13] Bednarz W. 2005. Wybrane element wspoma gającego leczenia chorób przyzębia. e-Dentico 1: 90-94 (in Polish).
  • [14] Jańczuk Z. 2001. Profilaktyka profesjonalna w stomatologii. PZWL, Warszawa (in Polish).
  • [15] Tartagila G.M., Kumar S., Fornari C.D., Corti E., Connelly S.T. 2016. Mouthwashes in the 21st century: a narrative review about active molecules and effectiveness on the periodontal outcomes. Expert Opinion on Drug Delivery 14: 973-982. doi:10.1080/17425247.2017.1260118
  • [16] Mayers S., Curran A. 2014. General and oral pathology for dental hygiene practice. FA Davis Corp., Philadelphia.
  • [17] https://www.ada.org/en/member-center/oral-healthtopics/mouthrinse
  • [18] Moroz J., Kurnatowski P. 2017. The in vitro activity of selected mouthrinses on standard strains of fungi. Annals Parasitology 63: 331-339. doi:10.17420/ap6304.120
  • [19] Kurnatowska A., Białasiewicz D., Domagalina E. 1985. Wstępna ocena aktywności rzęsistkobójczej nowych pochodnych benzoizoksazolinonu, benzoksazolinonu oraz benzotiazolinonu. Wiado mości Parazytologiczne 31: 175-180 (in Polish).
  • [20] Kadłubowski R. 1969. Sposoby oceny leków przeciwrzęsistkowych na podstawie krzywej wzrostu populacji rzęsistka. Wiadomosci Parazytologiczne 15: 399-401 (in Polish).
  • [21] Kurnatowska A.J. 1996. Prevalence of Trichomonas tenax (O.F. Muller, 1773/) Dobell, 1939 infection among dentist’s patients: the state of oral cavity, convergence with different clinical diagnoses. Minerva Ortognatodontica 14: 1-4.
  • [22] Sampaio-Maia B., Monteiro-Silva F. 2014. Acquisition and maturation of oral microbiome throughout childhood: an update. Denal Research Journal 11: 291-297.
  • [23] Mehr A.K., Zarandi A., Anush K. 2015. Prevalence of oral Trichomonas tenax in periodontal lesions of Down syndrome in Tabriz, Iran. Journal of Clinical and Diagnostic Research 9: ZC88-ZC90. doi:10.7860/JCDR/2015/14725.6238
  • [24] Derikvand N., Mahmoudvand H., Sepahvand A., Baharvand P., Kiafar M.M., Chiniforush N., Ghasemi S. 2018. Frequency and associated risk factors of Entamoeba gingivalis and Trichomonas tenax among patients with periodontitis in Western Iran. Journal of Research in Medical and Dentical Science 6: 99-103.
  • [25] Benabdelkader S., Andreani J., Gillet A., Terrer E., Pignoly M., Chaudet H., et al. 2019. Specific clones of Trichomonas tenax are associated with periodontitis. PLoS ONE 14: e0213338. doi:10.1371/journal.pone.0213338
  • [26] Kurnatowska A.J., Dudko A., Kurnatowski P. 2004. Inwazja Trichomonas tenax u pacjentów z chorobami przyzębia. Wiadomości Parazytologiczne 50: 397-403 (in Polish).
  • [27] Ribeiro L.C., Santos C., Benchimol M. 2015. Is Trichomonas tenax a parasite or a commensal? Protist 166: 196-210.
  • [28] Marty M., Lemaitre M., Kèmoun Ph., Morrier J-J., Monsarrat P. 2017. Trichomonas tenax and periodontal diseases: a concise review. Parasitology 144: 1417-1425. doi:10.1017/S0031182017000701
  • [29] Šegović S., Granić J., Buntak-Kobler D., Potočki- Tukša K.1993. Trichomonas tenax in human oral cavity. Acta Stomatologica Croatia 27: 255-261.
  • [30] Mahmoudvand H., Sepahvand A., Niazi M., Momeninejad N., Sepahvand S.M., Behzadian M. 2018. Prevalence and risk factors of oral cavity protozoa (Entamoeba gingivalis and Trichomonas tenax) among patients with dental cavity caries. Journal of Research in Medical and Dentical Science 6: 42-46.
  • [31] Duboucher C., Mogenet M., Périé G. 1995. Salivary trichomoniasis. A case report of infestation of a submaxillary gland by Trichomonas tenax. Archives of Pathology and Laboratory Medicine 119: 277-279.
  • [32] Duboucher C., Farto-Bensasson F., Chéron M., Peltier J.Y., Beaufils F., Périé G. 2000. Lymph node infection by Trichomonas tenax: report of a case with co-infection by Mycobacterium tuberculosis. Human Pathology 31:1317-1321. doi:10.1053/hupa.2000.18502
  • [33] Kuznetsov A.V. 2016. Morphological changes of cells of human tonsils affected by trichomonas. Saudi Journal of Biomedical Research 1: 20-21.
  • [34] Leterrier M., Morio F., Renard B.T., Poirier A.S., Mieqeville M., Chambreuil G. 2012. Trichomonads in pleural effusion: case report, literature review and utility of PCR for species identification. New Microbiology 35: 83-87.
  • [35] Lewis K.L., Doherty D.E., Ribes J., Seabolt J.P., Bensadoun E.S. 2003. Empyema caused by trichomonas. Chest 123: 291-292. https://doi.org/10.1378/chest.123.1.291
  • [36] Mallat H., Podglajen I., Lavarde V., Mainardi J-L., Frappier J., Cornet M. 2004. Molecular characterization of Trichomonas tenax causing pulmonary infection. Journal of Clinical Microbiology 42: 3886-3887.
  • [37] Marty M., Bonner M., Vaysse F. 2015. Observation of trichomonads infection in a child with periodontitis by direct microscopy at the dental office. Parasitology 142: 1440-1442. https://doi.org/10.1017/S0031182015000876
  • [38] Ghabanchi J., Zibaei M., Afkar M.D., Sarbazie A.H. 2010. Prevalence of oral Entamoeba gingivalis and Trichomonas tenax in patients with periodontal disease and healthy population in Shiraz, southern Iran. Indian Journal of Dentical Research 21: 89-91. doi:10.4103/0970-9290.62821
  • [39] Bergquist R. 2009. Parasitic infections affecting the oral cavity. Periodontology 2000 49: 96-105. https://doi.org/10.1111/j.1600-0757.2008.00294.x
  • [40] Bonner M., Amard V., Bar-Pinatel C., Charpentier F., Chatard J-M., Desmuyck Y. et al. 2014. Detection of the amoeba Entamoeba gingivalis in periodontal pockets. Parasite 21: 30. https://doi.org/10.1051/parasite/2014029
  • [41] Garcia G., Ramos F., Maldonado J., Fernandez A., Yáñez J., Hernandez L., Gaytán P. 2018. Prevalence of two Entamoeba gingivalis ST1 and ST2-kamaktli subtypes in the human oral cavity under various conditions. Parasitology Research 117: 2941-2948. doi:10.1007/s00436-018-5990-8
  • [42] Luszczak J., Bartosik M., Rzymowska J., Sochaczewska-Dolecka A., Tomaszek E., Wysokińska-Miszczuk J., Bogucka-Kocka A. 2016. The occurrence of Entamoeba gingivalis among patients with periodontal disease. Current Issues in Pharmacy and Medicine Sciences 29: 86-89.
  • [43] Ponce de Leon P., Zdero M., Vasconi M.D., Nocito I., Lucca A., Perez B. 2001. Relation between buccal protozoa and pH and salivary IgA in patients with dental prothesis. Revista do Instituto de Medicina Tropical de São Paulo 43: 241-242. https://doi.org/10.1590/s0036-46652001000400014

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-7ee97a31-31a3-483f-9db3-bfce6ed6f9e5
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.